Amgen and Arrakis collaborate to discover and develop targeted RNA degrader therapeutics Jan. 12, 2022
Mydecine completes model of new serotonin receptor for AI-driven drug discovery program Jan. 11, 2022
Amarna and Redoxis receive grant to support ALPHAVAC project in neurodegenerative diseases Jan. 11, 2022
BioNTech and Crescendo Biologics partner to develop immunotherapies for cancer and other diseases Jan. 11, 2022
RSS